Voorhees Township, NJ1 Active Studies

Multiple Sclerosis Clinical Trials in Voorhees Township, NJ

Find 1 actively recruiting multiple sclerosis clinical trials in Voorhees Township, NJ. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
220
Enrolling

Recruiting Multiple Sclerosis Studies in Voorhees Township

About Multiple Sclerosis Clinical Trials in Voorhees Township

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 1 multiple sclerosis clinical trials recruiting participants in Voorhees Township, NJ. These studies are seeking a combined 220 participants. Research is being sponsored by Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Voorhees Township — FAQ

Are there multiple sclerosis clinical trials in Voorhees Township?

Yes, there are 1 multiple sclerosis clinical trials currently recruiting in Voorhees Township, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Voorhees Township?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Voorhees Township research site will contact you about next steps.

Are clinical trials in Voorhees Township free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Voorhees Township studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 1 active trials in Voorhees Township are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 21, 2026 from ClinicalTrials.gov